Choriogonadotropin alfa biosimilar (Livzon Group)

重组人绒促性素生物类似药 (Livzon Group)

Report date: 2022/03/01 16:07:44

Base Information

Drug NameChoriogonadotropin alfa biosimilar (Livzon Group)
Drug Alias Name绒促性素α生物仿制药 (Livzon Group)丽得宝LZM-003
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionOvarian follicle stimulantsLuteinizing hormone/Choriogonadotropin receptor agonists
TargetsLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsInfertility, FemaleAnovulationInfertility
Global Approved IndicationsInfertility, FemaleAnovulation
Approved Indications in ChinaInfertility, FemaleAnovulation
Original Approved Country/TerritoryMainland China
Original Approved Date2021/04/13
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLivzon Pharmaceutical Group Inc
China Registration ClassN/A

Develop Information

Active CompaniesLivzon Mabpharm Inc
Inactive CompaniesLivzon Pharmaceutical Group Inc
Active IndicationsInfertility, FemaleAnovulation
Inactive IndicationsInfertility

Other Information

ATC CodeG03GA08
Related LinksN/A